Phase II Study of 2-Weekly CHOP+Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan (Zevalin) In Patients with Previously Untreated Diffuse Large B Cell Lymphoma (DLBCL): Final Analysis
Karmali, Reem, Manson, Andrew, Bueschel, Katherine, Shell, Kathryn, Gregory, Stephanie A., O'Brien, Teresa, Shammo, Jamile M., Larson, Melissa L, Venugopal, Parmeswaran
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lymphoma
Karmali, Reem, Larson, Melissa L., Wooldridge, James E., Gregory, Stephanie A., O'Brien, Teresa, Shammo, Jamile M., Bueschel, Katherine, Venugopal, Parameswaran
Published in Leukemia & lymphoma (01.11.2011)
Published in Leukemia & lymphoma (01.11.2011)
Get full text
Journal Article
Immune Ablation Using Cyclophosphamide without Stem Cell Rescue for Intractable Multiple Sclerosis and Its Variants
Nangia, Julie R, Shammo, Jamile M., Tilwalli, Shilpa D, Balabanov, Roumen, Stefoski, Dusan, Katsamakis, George, Ko, Michael, Shah, Neel B, Farhat, Mohamed I, Gimelfarb, Alla, Shell, Kathryn, Bueschel, Katherine, Gregory, Stephanie A.
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article